Basilea Pharmaceutica AG
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Basilea Pharmaceutica AG's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7% to $157,634,000. Profit margin reached 7%. Total operating expenses were $111,635,000.
Profit Margin
| 2014 | 42.49M | -41.54M | -97.76% |
|---|---|---|---|
| 2015 | 52.82M | -61.60M | -116.62% |
| 2016 | 65.98M | -51.28M | -77.73% |
| 2017 | 101.52M | -19.36M | -19.07% |
| 2018 | 132.55M | -31.35M | -23.65% |
| 2019 | 134.38M | -22.42M | -16.69% |
| 2020 | 127.62M | -14.72M | -11.53% |
| 2021 | 148.12M | -6.83M | -4.61% |
| 2022 | 147.76M | 12.14M | 8.22% |
| 2023 | 157.63M | 10.45M | 6.63% |
BSLN.SW Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 157.63M | 147.76M | 148.12M | 127.62M | 134.38M | 132.55M | 101.52M | 65.98M | 52.82M | 42.49M |
Cost of revenue | 26.79M | 26.80M | 24.07M | 24.05M | 18.86M | 125.24M | 64.08M | 53.79M | 60.07M | 54.37M |
Gross profit | 130.84M | 120.96M | 124.05M | 103.57M | 115.51M | 7.31M | 37.44M | 12.18M | -7.25M | -11.87M |
Operating exp. | ||||||||||
Research and development | 77.85M | 73.80M | 93.15M | 97.41M | 102.66M | 105.14M | 55.35M | 49.04M | 67.27M | 70.07M |
Selling and marketing | 0 | 30.81M | 29.72M | 29.42M | 30.05M | 31.40M | 53.13M | 200K | 300K | 100K |
Total operating expenses | 111.63M | 104.61M | 122.87M | 126.83M | 132.71M | 31.94M | 49.81M | 56.76M | 54.27M | 30.00M |
Operating income | 19.20M | 16.34M | 1.17M | -23.25M | -17.2M | -23.15M | -14.13M | -43.88M | -61.48M | -41.83M |
Other income (expenses), net | -8.74M | -4.24M | -7.96M | -6.44M | -5.18M | -8.00M | -4.89M | -7.06M | -35K | 310K |
Income before tax | 10.46M | 12.10M | -6.79M | -14.66M | -22.38M | -31.16M | -19.02M | -50.95M | -61.52M | -41.52M |
Income tax expense | 10K | -45K | 37K | 55K | 40K | 192K | 334K | 333K | 83K | 26K |
Net income | 10.45M | 12.14M | -6.83M | -14.72M | -22.42M | -31.35M | -19.36M | -51.28M | -61.60M | -41.54M |
Earnings per share | ||||||||||
Basic EPS | 0.87 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 | -1.79 | -5.07 | -6.09 | -4.17 |
Diluted EPS | 0.86 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 | -1.79 | -5.07 | -6.09 | -4.17 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |